Medfusion acquires appointment self-scheduling company NexSched

By Jonah Comstock

Patient engagement company Medfusion has acquired NexSched, which makes a patient-facing appointment scheduling tool. The terms of the deal were not disclosed.

“With NexSched, we are meeting the patient demand for an improved healthcare experience, and arming practices with the technology they need to be successful in a consumer-driven market,” Kimberly Labow, CEO of Medfusion, said in a statement. “By combining the forces of our powerful patient-centered solutions, we are enabling the patient to self-schedule their appointment, pay their co-pay or outstanding balance, and access their medical records all from their mobile device. This acquisition is a strong strategic fit with Medfusion's core offerings and accelerates the growth of our Patient Experience platform.”

Medfusion started out as a patient portal company way back in 2000. The company was acquired by Intuit in 2011 and then re-acquired by its original owner in 2013. It added a payment offering in 2015, shortly before a $3 million funding raise.

NexSched is an appointment scheduling platform that lets patients access a doctor’s schedule in a limited way and set their own appointments, leading to fewer no-shows and a decreased call volume.

“As a practicing physician, it was important to me to offer a solution that could decrease the expenses and frustrations inherent to a busy practice,” said Dr. Jeffrey Friedman, CFO of NexSched said in a statement. “Our patient self-scheduling solutions, in collaboration with Medfusion’s Patient Experience platform, allow practices to spend less time bogged down by scheduling, and focus on what matters most – providing exemplary care to patients.” 

Medfusion also announced a number of new app updates at HIMSS. The MedFusion app now makes it easier to share data with caregivers, allows users to connect to pharmacies and labs, and makes it easier to switch between account profiles for different members of the family.